fluorouracil and clodronic acid

fluorouracil has been researched along with clodronic acid in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's7 (77.78)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Blomqvist, C; Elomaa, I; Mäkelä, P; Saarto, T; Sarna, S; Välimäki, M1
Blomqvist, C; Elomaa, I; Mäkelä, P; Saarto, T; Välimäki, M; Vehmanen, L1
Arzumanov, AS; Iamshanov, VA; Ivanov, SD; Khazova, TV; Korytova, LI1
Blomqvist, C; Elomaa, I; Saarto, T; Taskinen, MR; Vehmanen, L1
Blomqvist, C; Elomaa, I; Risteli, J; Risteli, L; Saarto, T; Vehmanen, L1
Blomqvist, C; Elomaa, I; Saarto, T; Taube, T; Vehmanen, L1

Trials

5 trial(s) available for fluorouracil and clodronic acid

ArticleYear
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovary; Premenopause; Prospective Studies; Treatment Outcome

1997
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:18

    Topics: Absorptiometry, Photon; Administration, Oral; Adult; Amenorrhea; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Demineralization, Pathologic; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Methotrexate; Middle Aged; Ovarian Diseases; Prospective Studies

2001
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
    British journal of cancer, 2004, Aug-02, Volume: 91, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Humans; Lipoproteins; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Receptors, Estrogen; Tamoxifen

2004
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.
    Breast cancer research and treatment, 2004, Volume: 87, Issue:2

    Topics: Adult; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency

2004
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.
    Calcified tissue international, 2005, Volume: 77, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcification, Physiologic; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Humans; Ilium; Methotrexate; Middle Aged

2005

Other Studies

4 other study(ies) available for fluorouracil and clodronic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
[Prognostication of hematotoxicity for radio- and chemotherapy in patients with breast cancer].
    Voprosy onkologii, 2003, Volume: 49, Issue:5

    Topics: Adult; Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Hematologic Diseases; Humans; Methotrexate; Middle Aged; Prognosis; Radiotherapy, Adjuvant

2003